Interview: Pablo Granja & Escobar Granja: EG 2
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Tilray Acquires HelloMD to Build Out Canadian Medical Cannabis Network
NEW YORK – Tilray Brands Inc. has agreed to acquire HelloMD Corporation’s Canadian medical Cannabis assets, in a deal the companies say will build a fully vertically integrated medical Cannabis structure in Canada and add ...
DEA Opens Hearing on Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
